Compass Therapeutics Inc.

NASDAQ CMPX

Download Data

Compass Therapeutics Inc. Payables Turnover 1 year YoY Change (%) for the Trailing 12 Months (TTM) ending September 19, 2024

Compass Therapeutics Inc. Payables Turnover 1 year YoY Change (%) is NA for the Trailing 12 Months (TTM) ending September 19, 2024. Payables turnover measures the efficiency with which a company manages its accounts payable. It is calculated by dividing the cost of revenue by the accounts payable. This ratio indicates how quickly a company pays off its obligations to suppliers and vendors. A higher turnover suggests that the company is efficiently managing its accounts payable, while a lower ratio may indicate a slower payment process or potential liquidity issues. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
NASDAQ: CMPX

Compass Therapeutics Inc.

CEO Dr. Thomas J. Schuetz M.D., Ph.D.
IPO Date April 5, 2021
Location United States
Headquarters 80 Guest Street, Boston, MA, United States, 02135
Employees 32
Sector Healthcare
Industry Biotechnology
Description

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company's lead product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Similar companies

GLUE

Monte Rosa Therapeutics Inc

NA

NA

CGEM

Cullinan Oncology LLC

NA

NA

TYRA

Tyra Biosciences Inc

NA

NA

VIGL

Vigil Neuroscience Inc

NA

NA

PRTC

PureTech Health PLC

NA

NA

AVTE

Aerovate Therapeutics Inc

NA

NA

REPL

Replimune Group Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email